Loading...
Dispersion metrics may refine preclinical TdP risk assessment; leaves open prospective validation against QTc alone.
Key points are not available for this paper at this time.
A 2014 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: